Til lack of benefit depending on investigator judgment. The key endpoint
Chemexpress Til lack of advantage depending on investigator judgment. The key endpoint was PFS, assessed every eight weeks by central independent blinded critique employing modified RECIST (endpoints completely defined in Supplementary…